COVID-19: USFDA granted emergency use to Roche for antibody test

The Emergency use approval has been granted to Roche from the U.S. Food and Drug Administration (FDA) for an antibody test in determining if people have ever been infected with the covid-19, according to the Swiss drugmaker.

Roche had previously pledged to make its antibody test available by early May and to boost production by June to “high double-digit millions” per month.
The Basel-based company, which also makes separate molecular tests to identify people with active COVID-19 infections, said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%.

These rates will help in determining if a patient has been exposed to novel coronavirus, the respiratory disease caused by the coronavirus, and if the patient has ever developed antibodies against it. Various other companies including U.S. based Abbott Laboratories, Becton Dickinson and Co, Italy’s DiaSorin have also developed tests to identify antibodies that develop after somebody has come into contact with the virus.

  • Related Posts

    • Health
    • July 23, 2025
    • 139 views
    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    ‘Made in India’ Surgical Robot does a Trailblazer between India & France France/ India: Two continents as it were shrunk to an operation theatre, thanks to Made in India surgical…

    • Health
    • July 18, 2025
    • 787 views
    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Prodigal ‘Surgeon’ Son returns from London to put Bihar on Robotic Surgery Map New Delhi: Bihar healthcare may be on the cusp of being cutting edge as prospect of its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra